Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Prestwick3_000004

    Client Email Product

    Prestwick3_000004

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    104
    US DMFs Filed

    US DMFs Filed

    55
    CEP/COS Certifications

    CEP/COS Certifications

    39
    JDMFs Filed

    JDMFs Filed

    12
    Other Certificates

    Other Certificates

    29
    Other Suppliers

    Other Suppliers

    39
    API REF. PRICE (USD / KG)
    4

    API Market Place

    72
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    411
    Europe

    Europe

    375
    Canada

    Canada

    122
    Australia

    Australia

    71
    South Africa

    South Africa

    114
    Uploaded Dossiers

    Uploaded Dossiers

    419
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    4,628.00

    Annual Reports

    2,228.00

    FDF Market Place

    50
    EXCIPIENTS
    408
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    508

    USFDA Exclusivities

    40
    DIGITAL CONTENT

    Blog #PharmaFlow

    20

    News

    351
    REF STANDARD

    EDQM

    3

    USP

    3

    JP

    0

    Other Listed Suppliers

    9
    SERVICES
    2
    left grey arrow
    right gray arrow
    • TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE
    • TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE
    • TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE
    • TABLET;ORAL - 2.5MG;1GM
    • TABLET;ORAL - 2.5MG;500MG
    • TABLET;ORAL - 2.5MG;850MG
    • TABLET;ORAL - EQ 12.5MG BASE;1GM
    • TABLET;ORAL - EQ 12.5MG BASE;500MG
    • TABLET;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - 625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - 850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET, EXTENDED RELEASE;ORAL - 150MG;1GM
    • TABLET, EXTENDED RELEASE;ORAL - 150MG;500MG
    • TABLET, EXTENDED RELEASE;ORAL - 50MG;1GM
    • TABLET, EXTENDED RELEASE;ORAL - 50MG;500MG
    • TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • FOR SUSPENSION, EXTENDED RELEASE;ORAL - 500MG/5ML
    • TABLET, EXTENDED RELEASE;ORAL - 1GM
    • TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • SOLUTION;ORAL - 500MG/5ML
    • TABLET, EXTENDED RELEASE;ORAL - 1GM
    • TABLET, EXTENDED RELEASE;ORAL - 500MG
    • TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - 850MG;EQ 15MG BASE
    • TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE
    • TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE
    • TABLET;ORAL - 1GM;EQ 50MG BASE
    • TABLET;ORAL - 500MG;EQ 50MG BASE
    • TABLET;ORAL - 500MG;1MG
    • TABLET;ORAL - 500MG;2MG
    Full View ScreenFull Screen View
    Activist demands regulatory probe overcharging of diabetic drug Janumet by MSD
    Activist demands regulatory probe overcharging of diabetic drug Janumet by MSD

    https://www.pharmabiz.com/NewsDetails.aspx?aid=168279&sid=1

    PHARMABIZ
    02 Apr 2024
    Share Share
    CDE, China approved “Metformin Hydrochloride”
    CDE, China approved “Metformin Hydrochloride”

    https://www.iolcp.com//uploads/Intimation_19-02-2024.pdf

    PRESS RELEASE
    19 Feb 2024
    Share Share
    SugarMDs LLC Issues Voluntary Nationwide Recall of Advanced Glucose Support Supplements Capsules Due to Presence of Undeclared Glyburide and Metformin
    SugarMDs LLC Issues Voluntary Nationwide Recall of Advanced Glucose Support Supplements Capsules Due to Presence of Undeclared Glyburide and Metformin

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sugarmds-llc-issues-voluntary-nationwide-recall-advanced-glucose-support-supplements-capsules-due

    FDA
    15 Nov 2023
    Share Share
    Glenmark to launch Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin
    Glenmark to launch Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin

    https://www.indianpharmapost.com/news/glenmark-to-launch-a-triple-drug-fdc-of-teneligliptin-dapagliflozin-metformin-in-india-for-type-2-diabetes-14798

    INDIAN PHARMA POST
    18 Oct 2023
    Share Share
    Laurus Labs' Generic Metformin Hydrochloride Receives Approval in the U.S.
    Laurus Labs' Generic Metformin Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217631

    FDA
    05 Oct 2023
    Share Share
    Lupin acquires two diabetes brands from Boehringer Ingelheim
    Lupin acquires two diabetes brands from Boehringer Ingelheim

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-acquires-two-diabetes-brands-from-boehringer-ingelheim/articleshow/102841038.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    19 Aug 2023
    Share Share
    Dr. Reddy's Announces Launch of Saxagliptin and Metformin Hydrochloride Tablets
    Dr. Reddy's Announces Launch of Saxagliptin and Metformin Hydrochloride Tablets

    https://www.businesswire.com/news/home/20230810716002/en

    BUSINESSWIRE
    10 Aug 2023
    Share Share
    Dr. Reddy's Generic Metformin & Saxagliptin Hydrochloride Receives Approval in the U.S.
    Dr. Reddy's Generic Metformin & Saxagliptin Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207678

    FDA
    09 Aug 2023
    Share Share
    Akums gets DCGI nod for triple combination diabetes medication
    Akums gets DCGI nod for triple combination diabetes medication

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/akums-gets-dcgi-nod-for-triple-combination-diabetes-medication/articleshow/102172327.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    27 Jul 2023
    Share Share
    FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
    FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes

    https://www.prnewswire.com/news-releases/fda-approves-new-class-of-medicines-to-treat-pediatric-type-2-diabetes-301855985.html

    PR NEWSWIRE
    20 Jun 2023
    Share Share
    Vgyaan's Generic (Metformin Hydrochloride) Receives Approval in the U.S.
    Vgyaan's Generic (Metformin Hydrochloride) Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215629

    FDA
    20 Jun 2023
    Share Share
    Diabetes drug may be the pill for long Covid
    Diabetes drug may be the pill for long Covid

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/diabetes-drug-may-be-the-pill-for-long-covid/articleshow/100858324.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    09 Jun 2023
    Share Share
    Treating COVID with Metformin Reduces Long COVID Rates
    Treating COVID with Metformin Reduces Long COVID Rates

    https://www.prnewswire.com/news-releases/treating-covid-with-metformin-reduces-long-covid-rates-301846870.html

    PR NEWSWIRE
    09 Jun 2023
    Share Share
    Sun's Generic Linagliptin, Metformin HCL Receives Receives Approval in the U.S.
    Sun's Generic Linagliptin, Metformin HCL Receives Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211921

    FDA
    10 May 2023
    Share Share
    Alkem's Generic Dapagliflozin, Metformin HCL Receives Approval in the U.S.
    Alkem's Generic Dapagliflozin, Metformin HCL Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211563

    FDA
    04 May 2023
    Share Share
    Zydus' Generic Linagliptin, Metformin Hydrochloride Receives Approval in the U.S.
    Zydus' Generic Linagliptin, Metformin Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208449

    FDA
    30 Mar 2023
    Share Share
    Merck, Viatris agree to settle patent feud surrounding diabetes drugs
    Merck, Viatris agree to settle patent feud surrounding diabetes drugs

    https://endpts.com/merck-viatris-agree-to-settle-patent-feud-surrounding-diabetes-drugs/

    Paul Schloesser ENDPTS
    21 Mar 2023
    Share Share
    Enforcement Report - Week of March 15, 2023
    Enforcement Report - Week of March 15, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-15-2023-86840.pdf

    FDA
    15 Mar 2023
    Share Share
    NPPA fixes retail price of 74 drug formulations
    NPPA fixes retail price of 74 drug formulations

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-fixes-retail-price-of-74-drug-formulations/articleshow/98279741.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    27 Feb 2023
    Share Share
    USFDA approves Zydus Canagliflozin and Metformin Hydrochloride tablets
    USFDA approves Zydus Canagliflozin and Metformin Hydrochloride tablets

    https://health.economictimes.indiatimes.com/news/pharma/usfda-approves-zydus-canagliflozin-and-metformin-hydrochloride-tablets/98089916

    HEALTH ET
    20 Feb 2023
    Share Share
    Zydus' Generic Canagliflozin, Metformin Hydrochloride Receives Approval in the U.S.
    Zydus' Generic Canagliflozin, Metformin Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210542

    FDA
    16 Feb 2023
    Share Share
    Merck set to remove cancer-causing chemical from top diabetes drugs
    Merck set to remove cancer-causing chemical from top diabetes drugs

    https://www.reuters.com/business/healthcare-pharmaceuticals/merck-set-remove-cancer-causing-chemical-top-diabetes-drugs-bloomberg-news-2023-01-17/

    REUTERS
    18 Jan 2023
    Share Share
    Micro's Generic Metformin Hydrochloride Receives Approval in the U.S.
    Micro's Generic Metformin Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212448

    FDA
    10 Jan 2023
    Share Share
    Torrent enters into co-marketing partnership with Boehringer Ingelheim India
    Torrent enters into co-marketing partnership with Boehringer Ingelheim India

    https://www.indianpharmapost.com/news/torrent-enters-into-co-marketing-partnership-with-boehringer-ingelheim-india-13452

    INDIANPHARMAPOST
    15 Dec 2022
    Share Share
    Emmes acquires Clinical Edge; Expands global reach
    Emmes acquires Clinical Edge; Expands global reach

    http://www.pharmabiz.com/NewsDetails.aspx?aid=153605&sid=2

    PHARMABIZ
    30 Sep 2022
    Share Share
    US Court of Appeals for Circuit Rules in Favor of Merck in Patent Lawsuit
    US Court of Appeals for Circuit Rules in Favor of Merck in Patent Lawsuit

    https://www.businesswire.com/news/home/20220929005889/en

    BUSINESSWIRE
    29 Sep 2022
    Share Share
    Tiefenbacher Successfully Launches Generic Version Diabetis Med Vildagliptin
    Tiefenbacher Successfully Launches Generic Version Diabetis Med Vildagliptin

    https://tiefenbachergroup.com/2022/09/08/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-generic-version-of-the-diabetis-medicine-vildagliptin-and-vildagliptin-metformin-in-africa/

    PRESS RELEASE
    08 Sep 2022
    Share Share
    U.S. District Court Rules In Favor of Merck in Sitagliptin Patent Lawsuit
    U.S. District Court Rules In Favor of Merck in Sitagliptin Patent Lawsuit

    https://www.merck.com/news/u-s-district-court-rules-in-favor-of-merck-in-sitagliptin-phosphate-patent-lawsuit/

    PRESS RELEASE
    01 Sep 2022
    Share Share
    Pricing authority caps rates of key diabetes drugs
    Pricing authority caps rates of key diabetes drugs

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pricing-authority-caps-rates-of-key-diabetes-drugs/articleshow/93785721.cms

    Teena Thacker ECONOMIC TIMES
    25 Aug 2022
    Share Share
    VistaPharm's Generic Metformin Hydrochloride Receives Approval in the U.S.
    VistaPharm's Generic Metformin Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212677

    FDA
    19 Aug 2022
    Share Share
    Zydus receives final FDA approval for type 2 diabetes drug
    Zydus receives final FDA approval for type 2 diabetes drug

    https://health.economictimes.indiatimes.com/news/pharma/zydus-receives-final-fda-approval-for-type-2-diabetes-drug/92797033

    ET HEALTH
    11 Jul 2022
    Share Share
    Zydus Pharmaceuticals Generic Empagliflozin Receives Approval in US
    Zydus Pharmaceuticals Generic Empagliflozin Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212198

    FDA
    07 Jul 2022
    Share Share
    Accord Healthcare Vildagliptin/Metformin HCL Receives Approval in Europe
    Accord Healthcare Vildagliptin/Metformin HCL Receives Approval in Europe

    https://www.ema.europa.eu/en/documents/overview/vildagliptin/metformin-hydrochloride-accord-epar-medicine-overview_en.pdf

    EMA
    17 Jun 2022
    Share Share
    Advancing nitrosamines analysis with gas chromatography
    Advancing nitrosamines analysis with gas chromatography

    https://www.europeanpharmaceuticalreview.com/news/172292/advancing-nitrosamines-analysis-with-gas-chromatography/

    Hannah Balfour EUROPEANPHARMACEUTICALREVIEW
    16 Jun 2022
    Share Share
    Prinston's Generic Metformin HCL Receives Approval in the U.S.
    Prinston's Generic Metformin HCL Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212681

    FDA
    09 Jun 2022
    Share Share
    Majority of metformin drugs have acceptable nitrosamine levels, finds study
    Majority of metformin drugs have acceptable nitrosamine levels, finds study

    https://www.europeanpharmaceuticalreview.com/news/171874/majority-of-metformin-drugs-have-acceptable-nitrosamine-levels-finds-study/

    EUROPEANPHARMACEUTICALREVIEW
    01 Jun 2022
    Share Share
    Enforcement Report - Week of April 13, 2022
    Enforcement Report - Week of April 13, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-13-2022-1649826529.pdf

    FDA
    13 Apr 2022
    Share Share
    Mylan's Generics Sitagliptin & Metformin HCl Receives Approval in Europe
    Mylan's Generics Sitagliptin & Metformin HCl Receives Approval in Europe

    https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-metformin-hydrochloride-mylan

    EMA
    08 Mar 2022
    Share Share
    First oral diabetes treatment approved in Europe for use during pregnancy
    First oral diabetes treatment approved in Europe for use during pregnancy

    http://www.pharmafile.com/news/609109/first-oral-diabetes-treatment-approved-europe-use-during-pregnancy

    PHARMAFILE
    01 Mar 2022
    Share Share
    Glucophage® Approved in Europe for Use During Pregnancy
    Glucophage® Approved in Europe for Use During Pregnancy

    https://www.businesswire.com/news/home/20220227005209/en

    BUSINESSWIRE
    28 Feb 2022
    Share Share
    Daewoong Announces Successful Phase 3 Topline Results for Enavogliflozin TCT
    Daewoong Announces Successful Phase 3 Topline Results for Enavogliflozin TCT

    https://www.prnewswire.com/news-releases/daewoong-pharmaceutical-announces-successful-phase-3-topline-results-for-new-antidiabetic-drugs-triple-combination-therapy-301490372.html

    PRNEWSWIRE
    25 Feb 2022
    Share Share
    Sciegen Pharms' Generic Metformin Hydrochloride Receives Approval in the U.S.
    Sciegen Pharms' Generic Metformin Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214629

    FDA
    22 Feb 2022
    Share Share
    Enforcement Report - Week of January 19, 2022
    Enforcement Report - Week of January 19, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-19-2022-1642582122.pdf

    FDA
    19 Jan 2022
    Share Share
    Recall report: Another month, another issue with NDMA
    Recall report: Another month, another issue with NDMA

    https://endpts.com/recall-report-another-month-another-issue-with-ndma/

    J. Sullivan ENDPTS
    12 Jan 2022
    Share Share
    Dr. Reddy's Generic Veraring Receives Approval in the U.S.
    Dr. Reddy's Generic Veraring Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207577

    FDA
    08 Dec 2021
    Share Share
    NPPA fixes retail price of 20 new drugs
    NPPA fixes retail price of 20 new drugs

    http://www.pharmabiz.com/NewsDetails.aspx?aid=144456&sid=1

    PHARMABIZ
    06 Dec 2021
    Share Share
    Harman's Generic Metformin Hydrochloride Receives Approval in the U.S.
    Harman's Generic Metformin Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213320

    FDA
    03 Dec 2021
    Share Share
    DawaaDost announces one day’s Diabetes course of ‘Metformin 1000 mg’
    DawaaDost announces one day’s Diabetes course of ‘Metformin 1000 mg’

    https://www.expresspharma.in/dawaadost-announces-one-days-diabetes-course-of-metformin-1000-mg-at-re-1-per-day/

    EXPRESSPHARMA
    13 Nov 2021
    Share Share
    DawaaDost: 1 day’s diabetes course of ‘Metformin 1000 mg’ at 1 Rs. per day
    DawaaDost: 1 day’s diabetes course of ‘Metformin 1000 mg’ at 1 Rs. per day

    http://www.pharmabiz.com/NewsDetails.aspx?aid=143921&sid=2

    PHARMABIZ
    12 Nov 2021
    Share Share
    Glenmark Pharma launches FDC drug for type 2 diabetes
    Glenmark Pharma launches FDC drug for type 2 diabetes

    http://www.pharmabiz.com/NewsDetails.aspx?aid=143498&sid=2

    PHARMABIZ
    26 Oct 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    IOL Chemical

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search